Potentially, JQ1 can be used for the therapy of different diseases, including atherosclerosis [143], primary effusion lymphoma [175], skin cancers [176], ovarian cancer [164], colorectal cancer [177], osteosarcoma [178], breast cancer [179], brain tumor [180], prostate cancer [181], etc. JQ1 is not the only known BET inhibitor. This evidence concerns the gene DNER and ovarian carcinoma.